Group 1 - The company Zhengchuan Co., Ltd. forecasts a net profit attributable to shareholders of 18 million to 24 million yuan for the year 2025, representing a decrease of 29.2488 million to 35.2488 million yuan compared to the previous year, which is a year-on-year decline of 54.93% to 66.2% [1] - The primary reasons for the performance change include the deepening of pharmaceutical procurement policies, healthcare payment reforms, and intensified competition in the pharmaceutical market, leading to fluctuations in market demand from downstream customers, a decline in product prices, and a reduction in product sales, which resulted in decreased operating revenue and a year-on-year decline in gross profit [1]